Several other equities research analysts have also commented on MCRN. Robert W. Baird decreased their target price on shares of Milacron from $24.00 to $21.00 and set an outperform rating on the stock in a research report on Thursday, February 21st. Zacks Investment Research lowered shares of Milacron from a hold rating to a strong sell rating in a research report on Monday, March 11th. Two investment analysts have rated the stock with a sell rating and two have given a buy rating to the company. Milacron has an average rating of Hold and an average price target of $19.00.
Shares of NYSE MCRN opened at $12.38 on Monday. The firm has a market cap of $908.06 million, a price-to-earnings ratio of 6.96, a P/E/G ratio of 1.83 and a beta of 1.55. Milacron has a one year low of $11.11 and a one year high of $22.09.
Milacron (NYSE:MCRN) last issued its earnings results on Tuesday, April 30th. The industrial products company reported $0.27 EPS for the quarter, topping the consensus estimate of $0.26 by $0.01. The company had revenue of $248.70 million for the quarter, compared to analyst estimates of $279.52 million. Milacron had a net margin of 2.91% and a negative return on equity of 74.38%. The business’s revenue was down 13.9% on a year-over-year basis. During the same period in the previous year, the firm earned $0.40 EPS. As a group, sell-side analysts predict that Milacron will post 1.41 earnings per share for the current fiscal year.
In other Milacron news, insider Ling An-Heid sold 5,855 shares of the business’s stock in a transaction on Monday, March 4th. The shares were sold at an average price of $14.03, for a total transaction of $82,145.65. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, VP Hugh C. Odonnell sold 3,021 shares of the business’s stock in a transaction on Monday, March 4th. The stock was sold at an average price of $14.03, for a total transaction of $42,384.63. The disclosure for this sale can be found here. 3.40% of the stock is currently owned by insiders.
Several institutional investors have recently added to or reduced their stakes in MCRN. JPMorgan Chase & Co. boosted its position in shares of Milacron by 9.6% in the 3rd quarter. JPMorgan Chase & Co. now owns 462,427 shares of the industrial products company’s stock worth $9,364,000 after buying an additional 40,366 shares in the last quarter. Man Group plc purchased a new stake in shares of Milacron in the 3rd quarter worth about $241,000. Morgan Stanley boosted its position in shares of Milacron by 72.3% in the 3rd quarter. Morgan Stanley now owns 364,426 shares of the industrial products company’s stock worth $7,379,000 after buying an additional 152,927 shares in the last quarter. Vanguard Group Inc. boosted its position in shares of Milacron by 3.2% in the 3rd quarter. Vanguard Group Inc. now owns 5,941,454 shares of the industrial products company’s stock worth $120,315,000 after buying an additional 183,531 shares in the last quarter. Finally, Meeder Asset Management Inc. boosted its position in shares of Milacron by 54.0% in the 4th quarter. Meeder Asset Management Inc. now owns 2,312 shares of the industrial products company’s stock worth $28,000 after buying an additional 811 shares in the last quarter. Institutional investors and hedge funds own 95.91% of the company’s stock.
Milacron Company Profile
Milacron Holdings Corp. manufactures, distributes, and services engineered and customized systems within the plastic technology and processing industry in the United States and internationally. The company operates through three segments: Advanced Plastic Processing Technologies (APPT), Melt Delivery and Control Systems (MDCS), and Fluid Technologies (Fluids).
Featured Article: How do buyers and sellers choose a strike price?
To view ValuEngine’s full report, visit ValuEngine’s official website.
Receive News & Ratings for Milacron Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Milacron and related companies with MarketBeat.com's FREE daily email newsletter.